Pfizer Proceeds from Sale of Equity Method Investments decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $6.31B to $0.00.
mrk_proceeds_sale_equity_method_investments| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.49B | $3.55B | $6.31B | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | +1.7% | +77.8% | -100.0% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | +80.8% | -100.0% |